Could the blockchain be the salvation of the pharmaceutical industry?

“In order to add data to the ledger, all the computers have to agree on the information. If companies use this tool they will have to come to a consensus with all the stakeholders in the network before being able to register an information on the blockchain, the stakeholders therefore becoming midpoints taking part in the trial or regulatory organisations supervising the process. The conditions for a trial to continue can be coded into the blockchain under the format “IF (condition) THEN (consequence)”. Each document produced during the trial can be recorded on this blockchain such as the protocol or patient biological tests results. ..." Lire la suite